Carregant...

Strontium 89 for Palliation of Bone Metastases

At the University of Kansas Medical Center, systemic use of strontium 89 ((89)Sr), a betaemitting radioisotope, was evaluated in the treatment of metastatic carcinoma to bone for relief of bone pain. Eighty-five patients were treated with systemic (89)Sr in the dosage of 30 to 40 μCi/kg. All patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Reddy, Eashwer K., Robinson, Ralph G., Mansfield, Carl M.
Format: Artigo
Idioma:Inglês
Publicat: 1986
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2571189/
https://ncbi.nlm.nih.gov/pubmed/2419578
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!